Hypoglycemia increases serum interleukin-6 levels in healthy men and women

被引:60
作者
Dotson, Sarah [1 ]
Freeman, Roy [2 ]
Failing, Hannah J. [1 ]
Adler, Gail K. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet Hypertens, Boston, MA 02115 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
关键词
D O I
10.2337/dc07-2243
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE - Inflammation may have a major role in the pathogenesis and prognosis of critical illness. Hyperglycemia increases levels of the inflammatory cytokine interleukin-6 (IL-6) and is associated with increased risks of morbidity and mortality. Because hypoglycemia is also associated with adverse outcomes, we tested the hypothesis that hypoglycemia increases IL-6. RESEARCH DESIGN AND METHODS - Seventeen healthy men and women participated in hypoglycemic and euglycemic-hyperinsulinemic clamp studies (target blood glucose levels 2.7 and 5.0 mmol/l, respectively), separated by 1-3 months. IL-6, ACTH, and cortisol were measured at baseline and at 45, 75, 105, and 135 min after initiation of the insulin infusion. RESULTS - IL-6, ACTH, and cortisol levels increased significantly (P < 0.0001) during hypoglycemia but not euglycemia. IL-6 increased from mean +/- SEM 1.0 +/- 0.2 pg/ml at baseline to 2.6 +/- 0.2 pg/ml after 135 min of hypoglycemia, whereas IL-6 levels were unchanged during euglycemia. CONCLUSIONS - Hypoglycemia increases IL-6 levels in healthy individuals.
引用
收藏
页码:1222 / 1223
页数:2
相关论文
共 7 条
[1]
Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-α, but does not affect IL-1β, IL-6, or IL-10 [J].
de Galan, BE ;
Netea, MG ;
Smits, P ;
van der Meer, JWM .
CYTOKINE, 2003, 22 (3-4) :71-76
[2]
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans - Role of oxidative stress [J].
Esposito, K ;
Nappo, F ;
Marfella, R ;
Giugliano, G ;
Giugliano, F ;
Ciotola, M ;
Quagliaro, L ;
Ceriello, A ;
Giugliano, D .
CIRCULATION, 2002, 106 (16) :2067-2072
[3]
Interleukin-6 and diabetes - The good, the bad, or the indifferent? [J].
Kristiansen, OP ;
Mandrup-Poulsen, T .
DIABETES, 2005, 54 :S114-S124
[4]
Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-α, and FFAs to low-dose endotoxemia in humans [J].
Krogh-Madsen, R ;
Moller, K ;
Dela, F ;
Kronborg, G ;
Jauffred, S ;
Pedersen, BK .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (05) :E766-E772
[5]
Dose-dependent effects of recombinant human interleukin-6 on glucose regulation [J].
Tsigos, C ;
Papanicolaou, DA ;
Kyrou, I ;
Defensor, R ;
Mitsiadis, CS ;
Chrousos, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4167-4170
[6]
Tight blood glucose control with insulin in the ICU - Facts and controversies [J].
Vanhorebeek, Ilse ;
Langouche, Lies ;
Van den Berghe, Greet .
CHEST, 2007, 132 (01) :268-278
[7]
Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced 14 ex vivo secretion of tumor necrosis factor-α [J].
Wasmuth, HE ;
Kunz, D ;
Graf, J ;
Stanzel, S ;
Purucker, EA ;
Koch, A ;
Gartung, C ;
Heintz, B ;
Gressner, AM ;
Matern, S ;
Lammert, F .
CRITICAL CARE MEDICINE, 2004, 32 (05) :1109-1114